Atlas Trials

Trial of Adjuvant XELOX Chemotherapy and Concurrent Capecitabine and Radiotherapy for Resected Gastric Carcinoma

Clinical trial NCT01711242 · COMPLETED

Trial details

NCT number
NCT01711242
Sponsor
xie congying
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Gastric Cancer
Start date
2012-01-01
Primary completion
2020-01-01
Enrollment
208

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.